Verily, the life sciences group owned by Alphabet, laid off staff this week as part of a restructuring in its molecular sciences group, Business Insider has learned. Verily spokesperson Steven Cooper confirmed the cuts in an email to BI, stating that the affected employees worked on Verily's Immune Profiler project, which studies the human immune system for improving disease management. He declined to share the exact number of employees cut, but one source familiar with the situation said 35-40 people were affected. Verily is in the process of separating from Alphabet's infrastructure, part of a project named Flywheel that BI first reported on in 2021. It has set the end of 2024 as the deadline for detachment, a person familiar with the project told BI.

---

Persons: Verily, Steven Cooper, Cooper, Stephen Gillett, Andy Conrad, Amy Abernethy, Stat, Myoung Cha Organizations: Business, Apple Health